Abstract:Abstract Background Mutations in PIGN , resulting in a glycosylphosphatidylinositol (GPI) anchor deficiency, typically leads to multiple congenital anomalies-hypotonia-seizures syndrome. However, the link between PIGN and epilepsy or paroxysmal non-kinesigenic dyskinesia (PNKD) is not well-described. This study reported a patient with PIGN mutation leading to developmental and epileptic encephalopathy and PNKD, to expand upon the genotype–phenotype correlation of PIGN . Case presentation During the first 10 days of life, a girl exhibited paroxysmal staring episodes with durations that ranged from several minutes to hours. These episodes occurred 2–5 times daily and always occurred during wakefulness. Ictal electroencephalography revealed no abnormalities, and PNKD was diagnosed. The patient also exhibited severely delayed psychomotor development and generalized seizures at the age of 4 months. Results of brain magnetic resonance imaging and metabolic screenings were normal, but trio-based whole-exome sequencing identified two novel compound heterozygous PIGN mutations (NM_176787; c.163C > T [p.R55 > X] and c.283C > T [p.R95W]). Flow cytometry analysis of the patient’s granulocytes revealed dramatically reduced expression of GPI-anchored proteins. This indicated that the mutations compromised GPI functions. The patient got seizure-free for 1 year, and her dyskinesia episodes reduced significantly (1–2 times/month) after treatment with levetiracetam (600 mg/day) and clonazepam (1.5 mg/day). No progress was observed with respect to psychomotor development; however, no craniofacial dysmorphic features, cleft lip/palate, brachytelephalangy with nail hypoplasia, and internal malformations have been observed until now (6 years of age). Conclusion This is the first study to document developmental and epileptic encephalopathy with PNKD in a human with PIGN mutations. This report expanded our understanding of the genotype–phenotype correlation of PIGN, and PIGN may be considered a potentially relevant gene when investigating cases of epilepsy or PNKD.

Identification of CNTN2 as a genetic modifier of PIGA-CDG through pedigree analysis of a family with incomplete penetrance and functional testing in Drosophila

Drosophila models of PIGA-CDG mirror patient phenotypes

Drosophila models of phosphatidylinositol glycan biosynthesis class A congenital disorder of glycosylation (PIGA-CDG) mirror patient phenotypes

Homozygous PIGT Mutation Lead to Multiple Congenital Anomalies-Hypotonia Seizures Syndrome 3.

Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome 2 Caused by a Novel PIGA Variant Not Associated with a Skewed X-Inactivation Pattern

Identification and characterization of a new variation in DPM2 gene in two Chinese siblings with mild intellectual impairment

Identification of a Novel Splicing Variant in the Phosphatidylinositol Glycan Class S (PIGS) Gene That is Associated with Early Onset Epilepsy, Severe Developmental Delay, and Ventricular Septal Defect: a Case Report

Evolutionary rate covariation is pervasive between glycosylation pathways and points to potential disease modifiers

A novel germline PIGA mutation in Ferro-Cerebro-Cutaneous syndrome: a neurodegenerative X-linked epileptic encephalopathy with systemic iron-overload

Identification of two novel variants in ALG11 causing congenital disorder of glycosylation

Compound heterozygous mutations of NTNG2 cause intellectual disability via inhibition of the CaMKII signaling

Testing SIPA1L2 as a modifier of CMT1A using mouse models

Missense variant in PIGM associated with severe cystic encephalomalacia and portal vein thrombosis: Phenotypic and genotypic expansion of the glycosylphosphatidylinositol biosynthesis defect-1 (GPIBD1)

Congenital diaphragmatic hernia in siblings with PIGA-related congenital disorder of glycosylation

A novel homozygous variant of the PIGK gene caused by paternal disomy in a patient with neurodevelopmental disorder, cerebellar atrophy, and seizures

“Genotype-First” Approaches on a Curious Case of Idiopathic Progressive Cognitive Decline

Neuronal loss of Impairs O-glycosylation and Leads to Neurobehavioral Deficits Mimicking GALNT2-CDG

Damaging novel mutations in PIGN cause developmental epileptic-dyskinetic encephalopathy: a case report

Digenic variants of planar cell polarity genes in human neural tube defect patients.

Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation

Uncovering Phenotypic Expansion in AXIN2-Related Disorders Using Precision Animal Modeling